What’s Under The Iceberg: GE Healthcare’s Deep Dive Look At Future Of Gene Therapy
• By William Looney
Cell and gene therapy represent a transformative advance in drug delivery and outcomes, with implications equally as important to human progress as the digital revolution that began three decades ago.In Vivo speaks with a key player in this evolving field, GE Healthcare’s strategy manager for cell and gene therapy and board member of the Alliance for Regenerative Medicine, Phil Vanek, PhD.
Phil Vanek, GE Healthcare's strategy manager for cell and gene therapy • Source: GE Healthcare
Technology around cell and gene therapy is progressing, with a simplified, cost-efficient improvement to today’s cumbersome viral vector delivery pathway likely in a matter of years.
GE Healthcare’s strategy manager for cell and gene therapy and board member of the Alliance for Regenerative Medicine, Phil...